The GLP-1 shortage ended. The adherence problem did not.
For several years, glucagon-like peptide-1 (GLP-1) medications seemed to dominate conversations in community pharmacy. Patients called asking whether specific products were available, prescriptions were transferred between pharmacies, and pharmacy staff spent considerable time checking inventories and monitoring shortages. It was…
For several years, glucagon-like peptide-1 (GLP-1) medications seemed to dominate conversations in community pharmacy. Patients called asking whether specific products were available, prescriptions were transferred between pharmacies, and pharmacy staff spent considerable time checking inventories and monitoring shortages. It was not unusual for patients to call multiple times or travel significant distances in search of a medication that was difficult to obtain.
GLP-1 receptor agonists, including semaglutide (Ozempic and Wegovy) and …
The GLP-1 shortage ended. The adherence problem did not.
